GR 135531 - CAS 190277-13-5
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C14H17N3O3
Molecular Weight:
275.31
COA:
Inquire
Targets:
Melatonin Receptor
Description:
GR 135531 is a high affinity agonist of MT3 melatonin receptors, with low affinity for MT1 and MT2 melatonin receptors. GR 135531 can be used to discriminate between the melatonin receptor subtypes.
Brife Description:
MT3 melatonin receptor agonist
Purity:
≥97% by HPLC
Synonyms:
GR 135531; GR135531; GR-1355315-Methoxycarbonylamino-N-acetyltryptamine; 5-MCA-NAT; methyl N-[3-(2-acetamidoethyl)-1H-indol-5-yl]carbamate
MSDS:
Inquire
InChIKey:
MPZVHKLZCUEJFO-UHFFFAOYSA-N
InChI:
InChI=1S/C14H17N3O3/c1-9(18)15-6-5-10-8-16-13-4-3-11(7-12(10)13)17-14(19)20-2/h3-4,7-8,16H,5-6H2,1-2H3,(H,15,18)(H,17,19)
Canonical SMILES:
CC(=O)NCCC1=CNC2=C1C=C(C=C2)NC(=O)OC
1.Melatonin inhibits tachykinin NK₂ receptor-triggered 5-HT release from guinea pig isolated colonic mucosa.
Kojima S;Tohei A;Ikeda M Br J Pharmacol. 2011 Mar;162(5):1179-85. doi: 10.1111/j.1476-5381.2010.01122.x.
BACKGROUND AND PURPOSE: ;Melatonin is involved in the regulation of colonic motility, and sensation, but little is known about the influence of melatonin on 5-hydroxytryptamine (5-HT) release from colonic mucosa. A tachykinin NK₂ receptor-selective agonist, [β-Ala⁸]-neurokinin A(4-10) [βAla-NKA-(4-10)] can induce 5-HT release from guinea pig colonic mucosa via NK₂ receptors on the mucosal layer. The present study was designed to determine the influence of melatonin on 5-HT release from guinea pig colonic mucosa, evoked by the NK₂ receptor agonist, βAla-NKA-(4-10).;EXPERIMENTAL APPROACH: ;The effect of melatonin was investigated on the outflow of 5-HT and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) from muscle layer-free mucosal preparations of guinea pig colon, using high-performance liquid chromatography with electrochemical detection.;KEY RESULTS: ;Melatonin caused a sustained decline in the βAla-NKA-(4-10)-evoked 5-HT outflow from the muscle layer-free mucosal preparations, but failed to affect its metabolite 5-HIAA outflow. The specific MT₃ receptor agonist, 5-methoxycarbonylamino-N-acetyltryptamine mimicked the inhibitory effect of melatonin on βAla-NKA-(4-10)-evoked 5-HT outflow.
2.Effect of Melatonin and 5-Methoxycarbonylamino-N-Acetyltryptamine on the Intraocular Pressure of Normal and Glaucomatous Mice.
Martínez-Águila A;Fonseca B;Pérez de Lara MJ;Pintor J J Pharmacol Exp Ther. 2016 May;357(2):293-9. doi: 10.1124/jpet.115.231456. Epub 2016 Mar 3.
Melatonin is a neurohormone that is produced not only by the pineal gland but also by several ocular structures. One of the main physiologic roles of melatonin is the reduction of intraocular pressure (IOP). Using both control C57BL/6J and glaucomatous DBA/2J mice as well as TonoLab tonometry, this study evaluated the effect of melatonin and 5-methoxycarbonylamino-N-acetyltryptamine (5-MCA-NAT) when glaucomatous pathology was fully established and compared pharmacological behavior in treated mice versus control mice. In addition, 5-MCA-NAT was tested to determine its effects on ameliorating increased IOP in a glaucoma model. The results demonstrate that melatonin and 5-MCA-NAT can reduce IOP in a concentration-dependent manner. The EC50values for melatonin in control and glaucomatous animals were 34µM and 50µM, respectively. Interestingly, melatonin decreased IOP in 19.4% ± 3.7% and 32.6% ± 6.0% of control and glaucomatous mice, respectively, when the animals were studied at age 12 months. 5-MCA-NAT reduced IOP in the same manner and was able to stop IOP progression in glaucomatous mice. Use of melatonin receptor antagonists showed that hypotensive effects were blocked by the MT2receptor antagonists luzindole and 4-phenyl-2-propionamidotetralin in the case of melatonin and by only 4-phenyl-2-propionamidotetralin in the case of 5-MCA-NAT.
3.MT2 receptors mediate the inhibitory effects of melatonin on nitric oxide-induced relaxation of porcine isolated coronary arteries.
Tunstall RR;Shukla P;Grazul-Bilska A;Sun C;O'Rourke ST J Pharmacol Exp Ther. 2011 Jan;336(1):127-33. doi: 10.1124/jpet.110.174482. Epub 2010 Oct 19.
Previous studies from our laboratory demonstrated that melatonin inhibits nitric oxide (NO)-induced relaxation in porcine coronary arteries. The present study was designed to further characterize the mechanisms underlying this inhibitory effect of melatonin. Western immunoblot studies identified the presence of melatonin type 2 (MT(2)) receptors, but not MT(1) or MT(3) receptors, in porcine coronary arteries. Immunohistochemical analysis revealed that MT(2) receptors colocalized with α-actin in the smooth muscle cell layer. In coronary arterial rings suspended in organ chambers for isometric tension recording, melatonin (10(-7) M) inhibited relaxations induced by the exogenous NO donor sodium nitroprusside (SNP; 10(-9) to 10(-5) M) and by the α(2)-adrenoceptor agonist 5-bromo-6-[2-imidazolin-2-yl-amino]-quinoxaline (UK14,304; 10(-9) to 10(-5) M), an endothelium-dependent vasodilator. The inhibitory effect of melatonin on SNP- and UK14,304-induced relaxations was abolished in the presence of the selective MT(2) receptor antagonists 4-phenyl-2-propionamidotetralin (4P-PDOT; 10(-7) M) and luzindole (10(-7) M). In contrast to melatonin, the selective MT(3) receptor agonist 5-methoxycarbonylamino-N-acetyltryptamine (5-MCA-NAT; 10(-7) M) had no effect on the concentration-response curves to either SNP or UK14,304.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Melatonin Receptor Products


LY 156735
(CAS: 118702-11-7)

This active molecular is high affinity nonselective melatonin receptors MT1 and MT2 agonist which is under development for the treatment of insomnia and other s...

CAS 93515-00-5 2-Iodomelatonin

2-Iodomelatonin
(CAS: 93515-00-5)

2-Iodomelatonin is a potent agonist of the melatonin receptors 1 (MT1) with Ki value of 28 pM. It could be used to identify, characterize and localize melatonin...

CAS 196597-26-9 Ramelteon

Ramelteon
(CAS: 196597-26-9)

Ramelteon has high affinity with recombinant human MT1 and MT2 receptors with pKi of 10.05 and 9.70, respectively.

CAS 80270-68-4 AH 001

AH 001
(CAS: 80270-68-4)

AH 001 is a potent melatonin agonist.

CAS 343263-95-6 DH 97

DH 97
(CAS: 343263-95-6)

DH 97 is a selective MEL-1B-R (melatonin receptor) antagonist.

CAS 1016-47-3 N-Acetyltryptamine

N-Acetyltryptamine
(CAS: 1016-47-3)

N-Acetyltryptamine is a structural analog of 5-methoxy-N-acetyltryptamine which acts as a melatonin receptor antagonist in chicken retina and frog skin, and as ...

CAS 620170-78-7 4-P-PDOT

4-P-PDOT
(CAS: 620170-78-7)

4-P-PDOT is a slelctive antagonist of MT2 melatonin receptor, and luzindole-an antagonist of both membrane receptors, on an oncostatic action of MLT. It display...

CAS 63762-74-3 6-Chloromelatonin

6-Chloromelatonin
(CAS: 63762-74-3)

6-Chloromelatonin is a potent agonist of the melatonin receptors, which is active at nanomolar concentrations. It shows higher affinity for binding to hamster b...

Chemical Structure

CAS 190277-13-5 GR 135531

Quick Inquiry

Verification code

Featured Items